These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7203608)

  • 1. Antihypertensive effect of riboflavin analogs in rats with mineralocorticoid-induced hypertension.
    Trachewsky D
    Hypertension; 1981; 3(1):75-80. PubMed ID: 7203608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone stimulation of riboflavin incorporation into rat renal flavin coenzymes and the effect of inhibition by riboflavin analogues on sodium reabsorption.
    Trachewsky D
    J Clin Invest; 1978 Dec; 62(6):1325-33. PubMed ID: 748381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of riboflavin analogues in spontaneously hypertensive rats.
    Trachewsky D; Kem DC
    J Lab Clin Med; 1985 Aug; 106(2):223-8. PubMed ID: 4020249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effects of low molecular mass potassium alginate extracted from brown algae on DOCA salt-induced hypertension in rats.
    Chen YY; Ji W; Du JR; Yu DK; He Y; Yu CX; Li DS; Zhao CY; Qiao KY
    Biomed Pharmacother; 2010 Apr; 64(4):291-5. PubMed ID: 19932586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
    Safaeian L; Emami R; Hajhashemi V; Haghighatian Z
    Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats.
    Fujita T; Sato Y
    Kidney Int; 1983 Dec; 24(6):731-9. PubMed ID: 6325798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effect of progesterone in rats with mineralocorticoid-induced hypertension.
    Wambach G; Higgins JR
    Am J Physiol; 1979 Apr; 236(4):E366-70. PubMed ID: 434199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats.
    Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A
    Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure.
    Alvarez G; Osuna A; Wangensteen R; Vargas F
    Hypertension; 2000 Mar; 35(3):752-7. PubMed ID: 10720590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats.
    Titze J; Luft FC; Bauer K; Dietsch P; Lang R; Veelken R; Wagner H; Eckardt KU; Hilgers KF
    Hypertension; 2006 Jun; 47(6):1101-7. PubMed ID: 16636196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diazoxide on serum and tissue electrolyte levels in rats with deoxycorticosterone acetate-induced hypertension.
    Nakai T
    J Pharm Sci; 1994 May; 83(5):704-7. PubMed ID: 8071825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.